SCHEMBL715670

SCHEMBL715670

[c]1ccccc1-c1ncnc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.55
PI4KA P42356 1/20 0.44
PI4K2B Q8TCG2 1/20 0.44
PI4K2A Q9BTU6 1/20 0.44
PI4KB Q9UBF8 1/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
GRM4 Q14833 1/20 0.41
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HTT P42858 3/20 0.39
EGFR P00533 3/20 0.39
ABCG2 Q9UNQ0 2/20 0.39
DAPK3 O43293 1/20 0.39
MAP4K4 O95819 1/20 0.39
ABL1 P00519 1/20 0.39
ERBB2 P04626 1/20 0.39
PIM1 P11309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3075421 0.78 ADORA2A (0.75) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL712286 0.73 GPR3 (0.42) ADORA2ALMNASMN1; SMN2HTTRAB9A
SCHEMBL715671 0.73 ADORA2A (0.72) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL3137107 0.71 MAPT (0.45) LMNASMN1; SMN2HRH4RAB9ATSHR
SCHEMBL21295844 0.71 NPC1 (0.46) GRM4SMN1; SMN2CSNK1A1ACVR1DYRK1A
SCHEMBL13911021 0.71 ADORA2A (0.64) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL4491347 0.71 ADORA2A (0.70) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL4640585 0.71 ADORA2A (1.00) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL29398384 0.71 ADORA2A (1.00) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL31022155 0.69 ADORA2A (0.96) ADORA2API4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771843-B2 Fluorene derivative, organic compound, and light-emitting element, light-emitting device, and electronic device using the compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-08 US disclosed
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound AFF2, MAPRE2, AFF4 ADORA2A 2026/4885PI4KA 2095/4885PI4K2B 2289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.